Skip to menu Skip to content Skip to footer

2014

Conference Publication

Multiple Mechanisms of Tolerance Characterize the Immune Response to Autologous Modified Dendritic Cells Exposed to Citrullinated Peptides in Patients with Rheumatoid Arthritis.

Law, Soi-Cheng, Nel, Hendrik, Mehdi, Ahmed, Le Cao, Kim-Anh and Thomas, Ranjeny (2014). Multiple Mechanisms of Tolerance Characterize the Immune Response to Autologous Modified Dendritic Cells Exposed to Citrullinated Peptides in Patients with Rheumatoid Arthritis.. 2014 ACR/ARHP Annual Meeting, Boston, MA United States, 14-19 November 2014. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1002/art.38914

Multiple Mechanisms of Tolerance Characterize the Immune Response to Autologous Modified Dendritic Cells Exposed to Citrullinated Peptides in Patients with Rheumatoid Arthritis.

2013

Conference Publication

Mucosal Associated Invariant T (Mait) Cell Numbers Are Reduced in the Peripheral Blood of Rheumatoid Arthritis Patients

Klinken, Elizabeth, Nel, Hanno and Thomas, Ranjeny (2013). Mucosal Associated Invariant T (Mait) Cell Numbers Are Reduced in the Peripheral Blood of Rheumatoid Arthritis Patients. Australasian Society of Clinical Immunology and Allergy (ASCIA) 24th Annual Scientific Meeting, Perth, Western Australia, 11-13 September 1013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12252

Mucosal Associated Invariant T (Mait) Cell Numbers Are Reduced in the Peripheral Blood of Rheumatoid Arthritis Patients

2012

Conference Publication

Outcome of a phase I trial of rheumavax in patients with rheumatoid arthritis

Nel, H., Law, S., Street, S., Ramnoruth, N., Shams, R., Pahau, H., Brunck, M., Hyde, C., O'Sullivan, B., Capini, C., Tran, A., Ng, J., Godfrey, D. and Thomas, R. (2012). Outcome of a phase I trial of rheumavax in patients with rheumatoid arthritis. 53rd Annual Scientific Meeting of the Australian Rheumatology Association in conjunction with Rheumatology Health Professionals, Canberra ACT, Australia, 12-15 May 2012. Richmond Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1445-5994.2012.02761.x

Outcome of a phase I trial of rheumavax in patients with rheumatoid arthritis